Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...
Despite being at higher risk of complications overall, Medicare beneficiaries who receive a Micra leadless pacemaker (Medtronic) fare better than those implanted with traditional transvenous systems, ...
Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...
Please provide your email address to receive an email when new articles are posted on . The first pacemaker implantation was performed in 1958, and the technology has undergone many advances since ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...
Patients who received leadless pacemakers experienced fewer short-term and mid-term complications overall than those who had traditional transvenous pacemakers, a Cleveland Clinic-led research study ...
A leadless right-ventricular pacemaker continued to show an edge over conventional transvenous pacemakers by triggering a substantially reduced rate of complications during the 6 months following ...
The human heart rate is under the influence of various hormonal and neural control mechanisms. Normally, conduction of an electrical impulse through the heart begins at the sinoatrial (SA) node and ...
There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...
MidMichigan's Heart and Vascular Program is now offering a new miniature leadless pacemaker implant for qualified patients with permanent atrial fibrillation. The MicraTM Transcatheter Pacing System, ...
Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...